|1.||Langen, Karl-Josef: 18 articles (10/2015 - 07/2003)|
|2.||Stoffels, Gabriele: 14 articles (10/2015 - 02/2006)|
|3.||Zhang, Guang-Yi: 13 articles (06/2012 - 05/2003)|
|4.||Druker, Brian J: 13 articles (06/2012 - 12/2003)|
|5.||Karumanchi, S Ananth: 12 articles (04/2015 - 10/2005)|
|6.||Neel, Benjamin G: 12 articles (01/2015 - 08/2002)|
|7.||Polakiewicz, Roberto D: 12 articles (12/2011 - 01/2005)|
|8.||Gilliland, D Gary: 12 articles (01/2009 - 01/2002)|
|9.||Sabel, Michael: 11 articles (10/2015 - 02/2005)|
|10.||Coenen, Heinz H: 11 articles (03/2015 - 07/2003)|
12/01/2015 - "In studies of cancer cell lines, OXA-11 inhibited FAK phosphorylation at phospho-tyrosine 397 with a mechanistic IC50 of 1 nM in TOV21G tumor cells, which translated into functional suppression of proliferation in 3-dimensional culture with an EC50 of 9 nM. "
01/01/2014 - "This is the first study to systematically search for mutations in the tyrosine kinome in clear cell endometrial tumors. "
03/01/2012 - "Mechanistic studies showed that the antitumor effects of the tyrosine isomers were mediated in part by early inhibition of the MAP/ERK pathway and inactivation of STAT3, potentially driving tumor cells into a state of dormancy in G(0)-phase. "
01/01/2012 - "The discovery of the viral oncogene Src (v-Src) and its cellular nontransforming counterpart (c-Src), as the first example of PTK, has opened a window to study the relationship between protein-tyrosine phosphorylation and the biology and medicine of cancer. "
08/01/2011 - "In this study, 3-[(76)Br]bromo-α-methyl-l-tyrosine ([(76)Br]BAMT) was designed, and its usefulness was evaluated as a novel PET tracer for imaging malignant tumors. "
01/01/2013 - "Therefore, this review aims to assess the efficacy of tyrosine supplementation for phenylketonuria. "
01/01/2010 - "Therefore, this review aims to assess the efficacy of tyrosine supplementation for phenylketonuria. "
09/01/2001 - "Tyrosine supplementation has not consistently been found to improve neuropsychologic function in phenylketonuria (PKU), possibly because of failure to achieve adequate levels of tyrosine in the brain. "
02/01/1998 - "To test the efficacy of tyrosine supplementation, as an adjunct to dietary treatment, on neuropsychological test performance in individuals with phenylketonuria. "
02/01/1998 - "Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria."
|3.||Breast Neoplasms (Breast Cancer)
04/23/2015 - "In the present study, we investigated the effects of the tyrosine phosphatase, SRC-homology 2 domain-containing phosphatase 2 (SHP2), on cell migration in metastatic triple-negative breast cancer (TNBC), an aggressive disease associated with a poor prognosis for which a targeted therapy is not yet available. "
01/01/2014 - "Our study confirms distinct prognostic relevance of STAT1 expression levels and STAT1 tyrosine phosphorylation in breast cancer patients and identifies an association of high STAT1 levels with elevated expression of STAT1 target genes and markers for infiltrating immune cells."
12/15/2013 - "The present study investigates the effect of a tyrosine-based benzoxazepine derivative in human breast cancer cells MCF-7 and MDA-MB-231 and in breast cancer animal model. "
01/01/2012 - "The purpose of this study was to develop an efficient way to synthesize (99m)Tc-O-[3-(1,4,8,11-tetraazabicyclohexadecane)-propyl]-tyrosine ((99m)Tc-N4-Tyrosine), a novel amino acid-based radiotracer, and evaluate its potential in breast cancer gamma imaging. "
08/01/2010 - "This study was to develop a (99m)Tc-labeled alpha-methyl tyrosine (AMT) using L,L-ethylenedicysteine (EC) as a chelator and to evaluate its potential in breast tumor imaging in rodents. "
06/15/2011 - "Many of these receptors utilize tyrosine phosphorylation cascades to initiate and terminate signals leading to cell migration and clearance of infection. "
09/01/2011 - "This study reports the efficient transduction of well-characterized, homogeneous cultures of human ASCs by rAAV serotypes 2, 5, and 6. Transduction with rAAV2 at high multiplicity of infection was associated with reduced cell viability; however, no adverse effect was seen with serotypes 5 and 6. A further increase in transduction efficiency was observed using a rAAV6 Y731F tyrosine capsid mutant. "
09/01/2011 - "Consistent with in vitro studies, DrrA-mediated AMPylation of a conserved tyrosine residue in the switch II region of Rab1 was detected during infection. "
06/15/2005 - "Furthermore, subsequent studies into the underlying mechanisms revealed that DV attenuated IFN-alpha-induced tyrosine-phosphorylation of Tyk2, an upstream molecule of STAT activation, but had no effect on expression of both IFN-alpha receptor 1 and IFN-alpha receptor 2. Moreover, DV infection by itself could activate STAT1 and STAT3 through IFN-alpha-dependent and both IFN-alpha-dependent and IFN-alpha-independent mechanisms, respectively. "
04/01/2005 - "In this study, we examined the kinetics and pattern of protein tyrosine phosphorylation induced by infection with a comprehensive collection of chlamydial strains exhibiting diversity in host, tissue, and disease tropisms. "
01/01/2012 - "In conclusion, the ability of tyrosine to increase the chlorinating activity of MPO at neutral pH and enhanced values of H(2)O(2) may be very effective for the specific enhancement of HOCl production under acute inflammation."
03/28/2014 - "Studies performed during the past decade, however, have identified new roles for platelet immunoreceptor tyrosine-based activation motif signaling in vascular integrity in utero and at sites of inflammation. "
03/01/2010 - "In this study we examined the effect of tyrosine nitration and colonic inflammation on Ca(2+) channel mediated phosphorylation of CREB and CRE activation. "
10/01/2002 - "Previous studies have shown that lipopolysaccharide-induced inflammation in the lung results in tyrosine nitration. "
07/01/2014 - "Mucosal biopsy specimens from patients with IBD retained inflammation-associated tyrosine phosphoprotein profiles ex vivo. "
|4.||Aspartic Acid (Aspartate)
|5.||Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
|8.||Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
|9.||Epidermal Growth Factor Receptor (EGF Receptor)
|1.||Drug Therapy (Chemotherapy)
|3.||Heterologous Transplantation (Xenotransplantation)